Probiotics in relapsing and chronic diarrhea

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 8, 2004, Pages 515-517

  Benchimol, Eric I ^a   Mack, David R ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Antibiotic associated diarrhea; Bifidobacterium; Bone marrow transplantation; Clostridium difficile; Lactobacillus; Leukemia

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; COTRIMOXAZOLE; CYTARABINE; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; PROBIOTIC AGENT; TIOGUANINE; VANCOMYCIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BIFIDOBACTERIUM BREVE; CASE REPORT; CHRONIC DIARRHEA; CLOSTRIDIUM DIFFICILE; COLITIS; DRUG WITHDRAWAL; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; MALE; OTITIS MEDIA; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SIALIDOSIS; WHOLE BODY RADIATION;

ANTI-INFECTIVE AGENTS; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CHRONIC DISEASE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METRONIDAZOLE; PROBIOTICS; RECURRENCE;

EID: 3843117843     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000133291.11443.a1     Document Type: Article

References (24)

1. Hogenauer C, Hammer HF, Krejs GJ, et al. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis. 1998;27:702-710.
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334-339.
3. Banerjee S, LaMont JT. Treatment of gastrointestinal infections. Gastroenterology. 2000;118:S48-S67.
4. Schweitzer MA, Sweiss I, Silver DL, et al. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients. Am Surg. 1996;62:603-607.
5. Joyce AM, Burns DL. Recurrent Clostridia difficile colitis. Tackling a tenacious nosocomial infection. Postgrad Med. 2002;112:53-54, 57-58, 65.
6. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br Med J. 2002;324:1361-1366.
7. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2002;16:1461-1467.
8. Van Niel CW, Feudtner C, Garrison MM, et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:67-684.
9. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis Sci. 1998;16:292-307.
10. Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2003;37:22-26.
11. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989;96:981-988.
12. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect. 1998;36:171-174.
13. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995;90:439-448.
14. Riquelme AJ, Calvo MA, Guzman AM, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol. 2003;36:41-43.
15. Biller JA, Katz AJ, Flores AF, et al. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr. 1995;21:224-226.
16. Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis. 2003;36:775-780.
17. Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 2002;35:1155-1160.
18. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123-127.
19. Cunningham-Rundles S, Ahrne S, Bengmark S, et al. Probiotics and immune response. Am J Gastroenterol. 2000;95:S22-S25.
20. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol. 1999;276:G941-G950.
21. Mack DR, Lebel S. The role of probiotics in the modulation of intestinal infections and inflammation. Curr Opin Gastroenterol. 2004;20:22-26.
22. Kohler H, McCormick BA, Walker WA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr. 2003;36:175-185.
23. Karjalainen T, Barc MC, Collignon A, et al. Cloning of a genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus. Infect Immun. 1994;62:4347-4355.
24. Urbancsek H, Kazar T, Mezes I, et al. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001;13:391-396.